Noortje van Herwaarden trainee in rheumatology, Aatke van der Maas rheumatologist and clinical epidemiologist, Michiel J M Minten research assistant, Frank H J van den Hoogen professor of rheumatology, head of department of rheumatology , Wietske Kievit assistant professor of health technology assessment , Ronald F van Vollenhoven professor of rheumatology and epidemiologist et al
van Herwaarden N, van der Maas A, Minten M J M, van den Hoogen F H J, Kievit W, van Vollenhoven R F et al.
Disease activity guided dose reduction and withdrawal of adalimumab or etanercept compared with usual care in rheumatoid arthritis: open label, randomised controlled, non-inferiority trial
BMJ 2015; 350 :h1389
doi:10.1136/bmj.h1389